Créer jeu
Jouer Relier
1. Classification: Monoamine Oxidase Inhibitors (MAOIs)
2. Classification: Selective Serotonin Reuptake Inhibitors (SSRIs)
3. Classification: Typical Antipsychotics/Neuroleptic Drugs
4. Classification: Atypical Antipsychotics/Neuroleptic Drugs
5. Classification: Drugs for Bipolar D/O's
6. Classification: CNS Stimulants

Prototype: Lithium (Lithobid)

Prototype: Phenelzine (Nardil)

Action: Alters sodium transport in nerve & muscle cells; inhibits release of norepi & dopamine but not serotonin.

Indication: Tx for depression in those unresponsive to other antidepressive therapy.

Prototype: Methylphenidate (Ritalin, Concerta)

Indication: Tx of depression, OCDs, panic attacks, bulimia, PTSD, social phobias, social anxiety d/o’s.

Action: Irreversibly inhibits MAO, allowing norepi, 5HT, & dopamine to accumulate in synaptic cleft.

Action: Blocks both dopamine receptors & serotonin receptors.

Prototype: Clozapine (Clozaril)

Indication: Tx of manic episodes of bipolar d/o's & maintenance tx of bipolar d/o's.

Action: Primarily dopamine receptor blockers

Prototype: Fluoxetine (Prozac)

Indication: May alleviate some of the unpleasant neurological effects and depression of typical antipsychotics.

Prototype: Chlorpromazine (Thorazine)

AEs: Causes several adverse effects including hypotension, anticholinergic effects, and extrapyramidal side effects (EPS)

Indication: Narcolepsy, attention deficit d/o.

Action: CNS stimulants act as cortical & RAS stimulants, possibly by increasing release of catecholamines from presynaptic neurons. Mild cortical stimulant.

Action: Inhibits CNS neuronal reuptake of 5HT (increases levels of 5HT in synaptic cleft), w/little effect on norepi.